TJP1 and Parkinson disease: Patients with PD exhibited decreased expression of key TJ proteins, including ZO-1 [151], Occludin [152], and Claudin-1 [153], a dysfunction that facilitates the translocation of gut-derived pathogens and pro-inflammatory mediators such as LPS into systemic circulation.